Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 73
Filter
1.
Urology ; 2024 Jun 11.
Article in English | MEDLINE | ID: mdl-38871305

ABSTRACT

OBJECTIVE: To assess the feasibility, safety, and predictive factors for the success of holmium laser enucleation of the prostate (HoLEP) with catheter removal and hospital discharge on the same day of the procedure. METHODS: This prospective study included 34 patients who underwent HoLEP using a 60-W holmium laser device and the Wolf Piranha morcellation system. Surgeries began at 10:30 am and the patients were expected to be discharged by 5 pm on the same day. The patients underwent a voiding trial to remove the urinary catheter before hospital discharge. Functional outcomes were assessed 90 days after the procedure. RESULTS: Mean (range) age, prostate-specific antigen value, and prostate weight were as follows: 63.4 (50-80) years, 4.81 (0.19-14) ng/mL, and 89.3 (33-258) g, respectively. The mean (range) enucleation and morcellation times were 56.2 (29-91) minutes and 14.67 (3-45) minutes, respectively. Thirty-one patients (91.1%) were discharged on the same day of the procedure after urinary catheter removal. CONCLUSION: The performance of HoLEP is safe on an outpatient basis. Same-day catheter removal is feasible and does not affect hospital discharge.

2.
Prostate ; 84(2): 166-176, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37839045

ABSTRACT

PURPOSE: Prostate cancer (PCa) is the leading cause of death among men in 48 countries. Genetic alterations play a significant role in PCa carcinogenesis. For the hypothesis of this research, five unique polymorphisms (SNP) were investigated in different genes that showed to be associated in different ways with PCa: rs4430796, rs2735839, rs4792311, rs12329760, and rs28931588, respectively for the genes HNF1B, KLK3, ELAC2, TMPRSS2-ERG, and CTNNB1. PATIENTS AND METHODS: Blood samples from 426 subjects were evaluated: 290 controls (161 females and 129 males) and 136 PCa patients. SNP were determined by real-time polymerase chain reaction. TaqMan SNP genotyping assay. In the control samples, the SNPs were defined in association with the self-reported ethnicity, and in 218 control samples with markers with ancestry indicators. The genes were in Hardy-Weinberg equilibrium. One hundred and seventy control samples were matched by ethnicity for comparison with the PCa samples. RESULTS: The G allele at rs28931588 was monomorphic in both patients and controls studied. Significant differences were observed in allelic and genotypic frequencies between the control and Pca samples in rs2735839 (KLK3; p = 0.002 and χ2 = 8.73 and p = 0.01, respectively), by the global frequency and in the dominant model rs2735839_GG (odds ratio [OR] = 0.51, p = 0.02). AA and GA genotypes at rs4792311 (ELAC2) were more frequent in patients with Gleason 7(4 + 3), 8, and 9 (n = 37%-59.7%) compared to patients with Gleason 6 and 7(3 + 4) (n = 26%-40.0%) conferring a protective effect on the GG genotype (OR = 0.45, p = 0.02). The same genotype showed an OR = 2.71 (p = 0.01) for patients with low severity. The HNF1B-KLK3-ELAC2-TMPRSS2-ERG haplotypes: GAAT, AAAT, GAGT, and AAGT were more frequent in patients with Pca with OR ranging from 4.65 to 2.48. CONCLUSIONS: Higher frequencies of risk alleles were confirmed in the SNPs, KLK3 rs2735839_A, ELAC2 rs4792311_A, and TMPRSS2 rs12329760_T in patients with Pca. Rs2735839_A was associated with risk of Pca and rs4792311_A with severity and Gleason score of 7(4 + 3) or greater. There is a need for careful observation of rs2735839 and rs4792311 in association with the prostatic biopsy due to the increased risk of Pca.


Subject(s)
Prostate-Specific Antigen , Prostatic Neoplasms , Male , Humans , Kallikreins/genetics , Genetic Predisposition to Disease , Prostatic Neoplasms/pathology , Genotype , Polymorphism, Single Nucleotide , Transcriptional Regulator ERG/genetics , Hepatocyte Nuclear Factor 1-beta/genetics , Neoplasm Proteins , beta Catenin/genetics
3.
Asian J Urol ; 10(2): 151-157, 2023 Apr.
Article in English | MEDLINE | ID: mdl-36942119

ABSTRACT

Objective: Radical prostatectomy is the recommended treatment for localized prostate cancer; however, it is an invasive procedure that can leave serious morbidity. Robot-assisted radical prostatectomy was introduced with the aim of reducing postoperative morbidity and facilitating rapid recovery compared to the traditional Walsh's open radical retropubic prostatectomy. Therefore, a protocol was developed to perform an open prostatectomy comparable to that performed by robotics, but without involving novel instrumentation. Methods: A total of 220 patients diagnosed with localized prostate cancer underwent radical prostatectomy. They were divided into two groups: anterograde technique (115 patients) and the retrograde method (105 patients). The study outcomes were observed 3 months after surgery. Results: No differences were found in terms of surgical time, hospital stay, and suction drainage. However, reduced bleeding was observed in the anterograde technique (p=0.0003), with rapid anastomosis duration (p=0.005). Among the patients, 60.9% undergoing the anterograde technique were continent 3 months after surgery compared to 42.9% treated by the retrograde method (p=0.007). Additionally, fewer complications in terms of the number (p=0.007) and severity (p=0.0006) were observed in the anterograde technique. Conclusion: The anterograde method displayed increased efficiency in reducing complications, compared to the retrograde technique.

4.
Radiol Bras ; 55(4): 242-252, 2022.
Article in English | MEDLINE | ID: mdl-35983342

ABSTRACT

In recent years, the development of new imaging techniques and scoring systems have improved the diagnosis and management of small renal masses. Imaging-based nephrometry scoring systems play an interesting role in the planning of nephron-sparing surgery, providing surgeons with the information necessary to determine the complexity of the renal mass, to deliver the appropriate postoperative care, and to predict adverse outcomes. The aim of this study was to review nephrometry scoring systems, evaluating their characteristics and the relationships among them. The urology and radiology communities should decide which nephrometry scoring system will prevail and be used in daily practice.


O diagnóstico e o manejo das pequenas massas renais têm sido aprimorados nos últimos anos com o desenvolvimento de técnicas de imagem e escores que desempenham papel interessante no planejamento da nefrectomia parcial, fornecendo informações importantes ao cirurgião para determinar o tipo de tratamento em relação a complexidade da massa renal, cuidados pós-operatórios e previsão de complicações após as cirurgias. O objetivo deste estudo é revisar os escores de nefrometria, suas características e relações entre eles no cenário da cirurgia. Os serviços de urologia e radiologia devem decidir qual é o melhor escore de nefrometria para ser utilizado na prática diária.

5.
Radiol. bras ; 55(4): 242-252, Aug. 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1394561

ABSTRACT

Abstract In recent years, the development of new imaging techniques and scoring systems have improved the diagnosis and management of small renal masses. Imaging-based nephrometry scoring systems play an interesting role in the planning of nephron-sparing surgery, providing surgeons with the information necessary to determine the complexity of the renal mass, to deliver the appropriate postoperative care, and to predict adverse outcomes. The aim of this study was to review nephrometry scoring systems, evaluating their characteristics and the relationships among them. The urology and radiology communities should decide which nephrometry scoring system will prevail and be used in daily practice.


Resumo O diagnóstico e o manejo das pequenas massas renais têm sido aprimorados nos últimos anos com o desenvolvimento de técnicas de imagem e escores que desempenham papel interessante no planejamento da nefrectomia parcial, fornecendo informações importantes ao cirurgião para determinar o tipo de tratamento em relação a complexidade da massa renal, cuidados pós-operatórios e previsão de complicações após as cirurgias. O objetivo deste estudo é revisar os escores de nefrometria, suas características e relações entre eles no cenário da cirurgia. Os serviços de urologia e radiologia devem decidir qual é o melhor escore de nefrometria para ser utilizado na prática diária.

6.
Int. braz. j. urol ; 48(1): 110-119, Jan.-Feb. 2022. tab, graf
Article in English | LILACS | ID: biblio-1356276

ABSTRACT

ABSTRACT Introduction: Nephrometric scores play an interesting role in nephron sparring surgery (NSS) planning. The aim of this study is to evaluate if R.E.N.A.L. score (RS) is capable to predict the occurrence of adverse events in laparoscopic NSS. Materials and Methods: We prospectively studied 150 laparoscopic NSS between 2015 and 2018 to evaluate the relationship between RS and incidence of adverse events. Clavien 3 or superior complications, warm ischemia time (WIT) over 30 minutes, tumor violation, positive surgical margins (PSM) and necessity of amplification of renal parenchyma during the resection of the masses to obtain free margins were considered as adverse events. We compared each item of the RS isolated and divided the patients between low risk and high risk. Results: Adverse results occurred in 48 cases (32%). Amplification of the margin of resection was observed in 28 cases (19%). WIT exceeded 30 minutes in 9 cases (6.1%), complications Clavien 3 or superior occurred in 13 cases (9%) and PSM were detected en 6 cases (4%). Comparing the patients with adverse outcomes and each item of the RS we did not find any statistical difference, but when divided into high risk and low risk, we found that patients in the high risk group had a higher tendency to present ad-verse results - 25.84% vs. 44.26% (p=0.03). Conclusions: RS system is a good way to predict adverse outcomes in NSS, especially in cases over 7. Further studies should focus on robotic approach and patient's characteristics other than the masses' aspects.


Subject(s)
Humans , Laparoscopy , Kidney Neoplasms/surgery , Retrospective Studies , Treatment Outcome , Nephrectomy/adverse effects , Nephrons/surgery
7.
Int Braz J Urol ; 48(1): 110-119, 2022.
Article in English | MEDLINE | ID: mdl-34528773

ABSTRACT

INTRODUCTION: Nephrometric scores play an interesting role in nephron sparring surgery (NSS) planning. The aim of this study is to evaluate if R.E.N.A.L. score (RS) is capable to predict the occurrence of adverse events in laparoscopic NSS. MATERIALS AND METHODS: We prospectively studied 150 laparoscopic NSS between 2015 and 2018 to evaluate the relationship between RS and incidence of adverse events. Clavien 3 or superior complications, warm ischemia time (WIT) over 30 minutes, tumor violation, positive surgical margins (PSM) and necessity of amplification of renal parenchyma during the resection of the masses to obtain free margins were considered as adverse events. We compared each item of the RS isolated and divided the patients between low risk and high risk. RESULTS: Adverse results occurred in 48 cases (32%). Amplification of the margin of resection was observed in 28 cases (19%). WIT exceeded 30 minutes in 9 cases (6.1%), complications Clavien 3 or superior occurred in 13 cases (9%) and PSM were detected en 6 cases (4%). Comparing the patients with adverse outcomes and each item of the RS we did not find any statistical difference, but when divided into high risk and low risk, we found that patients in the high risk group had a higher tendency to present ad-verse results - 25.84% vs. 44.26% (p=0.03). CONCLUSIONS: RS system is a good way to predict adverse outcomes in NSS, especially in cases over 7. Further studies should focus on robotic approach and patient's characteristics other than the masses' aspects.


Subject(s)
Kidney Neoplasms , Laparoscopy , Humans , Kidney Neoplasms/surgery , Nephrectomy/adverse effects , Nephrons/surgery , Retrospective Studies , Treatment Outcome
10.
Clin Anat ; 33(6): 906-910, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32239554

ABSTRACT

INTRODUCTION: The macroscopic dynamic of fetal penis development presents a pattern resembling the unfolding of a spiral, so congenital ventral penile curvature could indicate that this natural sequence has been interrupted. Our aim in this article is to offer a mathematical model of congenital ventral curvature of the penis. MATERIALS AND METHODS: Five individuals who presented with congenital ventral penile curvature and three who presented with acquired penile ventral curvature due to Peyronie's disease were evaluated. The penises were photographed during an induced erection test and the penile curvature patterns were compared with an equiangular spiral. When an association was found, a potential relationship to the golden spiral-a type of equiangular spiral-was also assessed. The mathematical spiral relationships were analyzed using Wolfram CDF Player® (Logarithmic Spiral) and PhiMatrix® software. The Wolfram software generated logarithmic spirals equivalent to the penile curvature with appropriate mathematical values. The PhiMatrix software, which builds any golden spirals from golden rectangles, was used to check whether the spiral was golden as well as equiangular. RESULTS: An equiangular spiral that was also golden was found in all cases of congenital ventral penile curvature. In contrast, none of the acquired penile ventral curvature cases showed a specific pattern. CONCLUSION: Congenital ventral penile curvature has the mathematical pattern of a golden spiral. Our results offer a mathematical algorithm for potential use in surgical reconstruction procedures, regenerative medicine, tissue engineering, robotics, and body-machine interfaces.


Subject(s)
Penile Erection/physiology , Penile Induration/physiopathology , Penis/physiopathology , Adolescent , Aged , Child , Humans , Infant , Male , Middle Aged , Models, Theoretical
11.
Urology ; 136: 257-262, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31669134

ABSTRACT

OBJECTIVE: To compare ultrasonographic patterns of 2-dimensional perineal ultrasonography in men in the preoperative and postoperative periods after transobturator sling deployment for the treatment of urinary incontinence after radical prostatectomy. Radiotherapy and radical prostatectomy are the primary treatments for localized prostate cancer. Studies comparing anatomic changes in men before and after radical prostatectomy based on perineal ultrasonography are scarce in the literature. METHODS: Thirty-one patients from 2 centers were selected for examination and surgery. They were allocated into mild and/or moderate and severe incontinence groups who underwent the transobturator sling procedure between August 2014 and August 2018. Perineal ultrasonography was performed in the preoperative period for 21 of these patients and 3-6 months postoperatively after the transobturator sling procedure for 30 patients. Hypermobility of the proximal urethra and voluntary contraction of the pelvic floor were evaluated during the Valsalva maneuver, perineal contraction and at rest. RESULTS: Clinical improvements of >50% were significantly more frequent in the mild and/or moderate vs severe incontinence group after male sling surgery (P = .035). Patients who demonstrated clinical improvement >50% showed a significantly greater displacement of the posterior portion of the bladder neck during contraction than those with clinical improvement <50% (P = .024). CONCLUSION: The most important finding of this study was the significant difference in the posterior displacement of the bladder neck during contraction in patients who showed an improvement >50% compared with those with an improvement <50%. These data support the use of perineal ultrasonography in evaluating and selecting patients for the male sling procedure.


Subject(s)
Perineum/diagnostic imaging , Postoperative Complications/diagnostic imaging , Postoperative Complications/surgery , Prostatectomy , Suburethral Slings , Urinary Incontinence/diagnostic imaging , Urinary Incontinence/surgery , Aged , Aged, 80 and over , Humans , Male , Middle Aged , Postoperative Period , Preoperative Period , Prospective Studies , Prostatectomy/methods , Ultrasonography/methods , Urologic Surgical Procedures, Male/methods
12.
Fisioter. Bras ; 20(2): 230-238, Maio 1, 2019.
Article in Portuguese | LILACS | ID: biblio-1281171

ABSTRACT

Controle eficiente dos mecanismos de fechamento uretral é essencial para continência urinária feminina, envolvendo mecanismo similar ao necessário para estabilidade sacroilíaca. Estudos demonstraram benefícios na reabilitação funcional do assoalho pélvico, após tratamento de pacientes com lombalgia, utilizando técnicas de manipulação osteopática. O objetivo primário deste estudo foi avaliar melhora da incontinência urinária após tratamento manipulativo osteopático musculoesquelético (TMO), associado com fisioterapia pélvica (FP). Participaram pacientes da divisão de fisioterapia da Policlínica Piquet Carneiro/UERJ, com diagnóstico de incontinência urinária não complicada, idade entre 21 e 65 anos, que responderam os questionários: International Consultation on Incontinence Questionnaire - Short Form - ICIQ, Stress Urinary Incontinance Questionnaire - SUIQ, Overactive Bladder Questionnaire - ICIQ-OAB qol, e o questionário de qualidade de vida e saúde geral ­ EQ5D. A força perineal foi avaliada através do teste de avaliação funcional do assoalho pélvico, e as pacientes foram divididas em dois grupos: no grupo FP submetidas ao protocolo de FP por 10 semanas, e no grupo TMO submetidas ao mesmo protocolo, associado com TMO, pelo mesmo período. No presente estudo, a utilização do TMO associado à FP obteve resultados semelhantes à utilização de FP isoladamente, não acrescentando melhora na resposta ao tratamento da incontinência urinária não complicada. (AU)


Effective control of urethral closure mechanisms is essential for female urinary continence, involving mechanism similar to that required for sacroiliac stability. Studies have demonstrated benefits in the functional rehabilitation of the pelvic floor, after treatment of patients with low back pain, using osteopathic manipulation techniques. Primary objective of this study was to evaluate the improvement of urinary incontinence after musculoskeletal manipulation (OMT), associated with pelvic physiotherapy (PF). Patients from the Physiotherapy Division of the Policlínica Piquet Carneiro/UERJ, diagnosed with uncomplicated urinary incontinence, aged between 21 and 65 years, answered the questionnaires: International Consultation on Incontinence Questionnaire - Short Form - ICIQ, Stress Urinary Incontinence Questionnaire - SUIQ, Overactive Bladder Questionnaire - ICIQ-OAB qol, and the quality of life and general health questionnaire - EQ5D. The perineal force was evaluated through functional evaluation of the pelvic floor. Patients were divided: in the FP group submitted to the FP protocol, and in the OMT group submitted to the same protocol, associated with OMT, for 10 weeks. In the present study the use of OMT associated with PF, obtained results similar to the use of PF alone, and did not add improvement in the response to treatment of uncomplicated urinary incontinence. (AU)


Subject(s)
Humans , Female , Urinary Incontinence , Musculoskeletal Manipulations , Manipulation, Osteopathic , Women's Health
13.
Int Braz J Urol ; 45(5): 1071-1072, 2019.
Article in English | MEDLINE | ID: mdl-30901175

ABSTRACT

INTRODUCTION: Robotic-assisted radical prostatectomy is the leading surgical technique and was discussed in Pasadena Consensus Panel (1). The goal of this study is to present the results of the first fifty-five patients submitted to Anterograde Anatomic Radical Retropubic Prostatectomy technique (R2PA2), without adding complexity or cost. MATERIALS AND METHODS: Fifty-five eligible men with localized prostate cancer underwent R2PA2 from January, 2016 to December, 2017. The technique was previously described (2): the main surgical steps were anterograde dissection, ligation of the dorsal vascular complex without dividing, preservation of the bladder neck, nerve sparing, preservation of Denonvilliers' fascia and confection of the running suture anastomosis. All patients were operated on by second-year residents. RESULTS: All procedures were completed as planned, but one converted to retrograde prostatectomy (mean duration, 163.40 minutes; hospital stay, 4 days with 4.20 days of drainage; indwelling vesical catheterization of 9.80 days). Positive surgical margin was found in six T2 staging patient (10.90%) and five T3 (9.10%). Biochemical PSA recurrence occurred in three patients (5.50%). Twenty-four (43.60%) were continent immediately after indwelling catheter removal, seventeen (30.90%) did not wear a pad at one postoperative month while eighteen (30%) used only one safety pad. Five minor complications occurred. CONCLUSION: We were able to perform R2PA2 allowing men who do not have access to this new technology to be operated on with the same technique used in robotic surgery. This method was reproducible by low-volume prostate cancer surgeons; help inexperienced surgeons to develop skills valuable to future training with robotic techniques. ACKNOWLEDGEMENTS This work was supported by the FAPERJ - Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro. Secretaria de Estado de Ciência, Tecnologia e Inovação do Governo do Estado do Rio de Janeiro, Brazil, and Pedro Ernesto University Hospital of the State University of Rio de Janeiro, Brazil. Available at: http://www.intbrazjurol.com.br/video-section/20180421_Carrerette_et_al.


Subject(s)
Prostatectomy/methods , Prostatic Neoplasms/surgery , Aged , Humans , Length of Stay , Male , Middle Aged , Operative Time , Reproducibility of Results , Treatment Outcome
14.
Lancet Oncol ; 19(2): 194-206, 2018 02.
Article in English | MEDLINE | ID: mdl-29326030

ABSTRACT

BACKGROUND: In the LATITUDE trial, addition of abiraterone acetate plus prednisone to androgen deprivation therapy (ADT) improved overall survival compared with placebos plus ADT in patients with newly diagnosed, high-risk, metastatic castration-naive prostate cancer. Understanding the effects of treatments on patient-reported outcomes (PROs) and health-related quality of life (HRQOL) is important for treatment decisions; therefore we aimed to analyse the effects of ADT plus abiraterone acetate and prednisone versus ADT plus placebos on PROs and HRQOL in patients in the LATITUDE study. METHODS: In the multicentre, international, randomised, phase 3 LATITUDE trial, eligible patients were aged 18 years or older, had newly diagnosed, high-risk, metastatic castration-naive prostate cancer confirmed by bone scan (bone metastases) or by CT or MRI (visceral, soft tissue, or nodal metastases), and an Eastern Cooperative Oncology Group (ECOG) performance status score of 2 or less. Patients from 235 clinical sites in 34 countries were randomly assigned (1:1) following a country-by-country scheme done by permuted block randomisation (with two blocks) and stratified by the presence of visceral metastasis and ECOG performance status to receive ADT plus 1000 mg oral abiraterone acetate and 5 mg oral prednisone once daily or ADT plus placebos. Selection of ADT, chemical or surgical, was at the investigator's discretion. The co-primary endpoints of the trial, overall survival and radiographic progression-free survival, have been published. PRO data were collected directly on electronic tablet devices at the clinical sites during screening and before any other visit procedure on day 1 of cycles 1-3, monthly during cycles 4-13, and then every 2 months until the end of treatment, by use of the Brief Pain Inventory-Short Form (BPI-SF), Brief Fatigue Inventory (BFI), Functional Assessment of Cancer Therapy Prostate scale (FACT-P), and the EuroQol (EQ-5D-5L) questionnaires. PRO analyses were an exploratory endpoint. Analyses were by intention-to-treat. Results from the first pre-planned interim analysis (Oct 31, 2016), are presented here. This ongoing study is registered with Clinicaltrials.gov, number NCT01715285. FINDINGS: Between Feb 12, 2013, and Dec 11, 2014, 1199 patients were randomly assigned: 597 to ADT plus abiraterone acetate and prednisone and 602 to ADT plus placebos. Median follow-up was 30·9 months (IQR 21·2-33·2) in the ADT plus abiraterone acetate and prednisone group versus 29·7 months (1·4-43·5; 16·1-31·3) in the ADT plus placebos group. Median time to worst pain intensity progression assessed by the BPI-SF score was not reached in either group (ADT plus abiraterone acetate and prednisone, not reached [95% CI not reached to not reached]; 25th percentile 11·07 months [95% CI 9·23-18·43]; ADT plus placebos group, not reached [95% CI not reached to not reached]; 25th percentile 5·62 [95% CI 4·63-7·39]; hazard ratio [HR] 0·63 [95% CI 0·52-0·77]; p<0·0001). Median time to worst fatigue intensity was not reached in either the ADT plus abiraterone acetate and prednisone group (not reached [95% CI not reached to not reached]; 25th percentile 18·4 months [95% CI 12·9-27·7]) or the ADT plus placebos group (not reached [95% CI not reached to not reached]; 25th percentile 6·5 months [95% CI 5·6-9·2]; HR 0·65 [95% CI 0·53-0·81], p=0·0001). Median time to deterioration of functional status assessed by the FACT-P total score scale was 12·9 months (95% CI 9·0-16·6) in the ADT plus abiraterone acetate and prednisone group versus 8·3 months (7·4-11·1) in the ADT plus placebos group (HR 0·85 [95% CI 0·74-0·99]; p=0·032). INTERPRETATION: The addition of abiraterone acetate plus prednisone to ADT in patients with newly diagnosed, high-risk metastatic castration-naive prostate cancer improved overall PROs by consistently showing a clinical benefit in the progression of pain, prostate cancer symptoms, fatigue, functional decline, and overall HRQOL. FUNDING: Janssen Research & Development.


Subject(s)
Abiraterone Acetate/therapeutic use , Androgen Antagonists/therapeutic use , Patient Reported Outcome Measures , Prednisone/therapeutic use , Prostatic Neoplasms, Castration-Resistant/drug therapy , Prostatic Neoplasms, Castration-Resistant/mortality , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Disease-Free Survival , Humans , Internationality , Kaplan-Meier Estimate , Magnetic Resonance Imaging/methods , Male , Middle Aged , Neoplasm Invasiveness/pathology , Neoplasm Staging , Proportional Hazards Models , Prostatic Neoplasms, Castration-Resistant/pathology , Quality of Life , Risk Assessment , Survival Analysis , Tomography, X-Ray Computed/methods , Treatment Outcome
15.
Int J Impot Res ; 30(1): 43-47, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29180798

ABSTRACT

This is an observational transversal cohort study in which we aim to analyze the Brazilian penis length and compare the penis size of the men self-declared as white (SDW) or black (SDB) skin color. Subjects were asked for self-declare according to their skin color, after that they have been invited to participate in a semi-structured interview so as to have their perception evaluated regarding their penis size and their self-esteem as well. Eventually, their penis length was measured with an anthropometric ruler. The men´s mean penis length who declared themselves as black skin color was 16.5 ± 1.7 cm (penis length in real fully-stretched flaccid length) and the men´s mean penis length who declared themselves as white skin color was 15.8 ± 1.6 cm (p < 0.001).The majority of either SDB (94.0%) or SDW (89.4%) are satisfied with their penis size (p = 0.464). We have shown that the man´s mean penis length who identifies himself as black is just a little bit bigger than the one who identifies himself as white. However, there were no significant difference between groups regarding self-assessment of genital body image.


Subject(s)
Penis/anatomy & histology , Adolescent , Adult , Aged , Aged, 80 and over , Anthropometry , Black People/statistics & numerical data , Body Image , Brazil , Cohort Studies , Humans , Male , Middle Aged , Organ Size , White People/statistics & numerical data , Young Adult
16.
World J Urol ; 34(1): 137-42, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26017888

ABSTRACT

PURPOSE: The use of minilaparoscopic instruments has gained interest in recent years, permitting a less invasive treatment for many surgical procedures. Its application in urological surgeries has not been established yet. METHODS: Between November 2012 and December 2014, 32 patients underwent minilaparoscopic surgeries, using 3.5-mm instruments. The procedures performed included pyeloplasties (16 cases), radical nephrectomies (2), simple nephrectomies (4), renal cyst decortication (5), ureterolithotomy (2) ureteral reimplantation (2) and partial ureterectomy (1). RESULTS: All the procedures were performed minilaparoscopically, except for one simple nephrectomy and one renal cyst decortication that were converted to a standard laparoscopic approach, due to intensive perioperative bleeding. One pyeloplasty had to be reoperated for a urinary fistula repair. All the patients had good-to-excellent cosmetic outcomes, except for one patient who developed keloids at her scars. Functional results were comparable to the ones described in the literature. CONCLUSION: Minilaparoscopy is a feasible option for patients and physicians searching for a even less invasive procedure compared with the laparoscopic approach, with better cosmetic and the same functional and oncologic outcomes.


Subject(s)
Kidney/surgery , Laparoscopy/methods , Minimally Invasive Surgical Procedures/methods , Ureter/surgery , Urologic Surgical Procedures/methods , Humans , Nephrectomy/methods , Replantation/methods , Ureteral Calculi/surgery
17.
Eur J Cancer ; 51(13): 1812-21, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26093811

ABSTRACT

BACKGROUND: This analysis was performed to further characterise treatment-emergent hypocalcaemia in patients with bone metastases receiving denosumab. METHODS: Laboratory abnormalities and adverse events of hypocalcaemia in patients with metastatic bone disease were analysed using data from three identically designed phase 3 trials of subcutaneous denosumab 120 mg (n = 2841) versus intravenous zoledronic acid 4 mg (n = 2836). RESULTS: The overall incidence of laboratory events of hypocalcaemia grade ⩾ 2 was higher with denosumab (12.4%) than with zoledronic acid (5.3%). Hypocalcaemia events were primarily grade 2 in severity and usually occurred within the first 6 months of treatment. Patients who reported taking calcium and/or vitamin D supplements had a lower incidence of hypocalcaemia. Prostate cancer or small-cell lung cancer, reduced creatinine clearance and higher baseline bone turnover markers of urinary N-telopeptide of type I collagen (uNTx; > 50 versus ⩽ 50 nmol/mmol) and bone-specific alkaline phosphatase (BSAP; > 20.77 µg/L [median] versus ⩽ 20.77 µg/L) values were important risk factors for developing hypocalcaemia. The risk associated with increased baseline BSAP levels was greater among patients who had > 2 bone metastases at baseline versus those with ⩽ 2 bone metastases at baseline. CONCLUSION: Hypocalcaemia was more frequent with denosumab versus zoledronic acid, consistent with denosumab's greater antiresorptive effect. Low serum calcium levels and potential vitamin D deficiency should be corrected before initiating treatment with a potent osteoclast inhibitor, and corrected serum calcium levels should be monitored during treatment. Adequate calcium and vitamin D intake appears to substantially reduce the risk of hypocalcaemia.


Subject(s)
Antineoplastic Agents/adverse effects , Bone Density Conservation Agents/adverse effects , Bone Neoplasms/drug therapy , Bone Neoplasms/secondary , Calcium/blood , Denosumab/adverse effects , Hypocalcemia/chemically induced , Biomarkers/blood , Clinical Trials, Phase III as Topic , Diphosphonates/adverse effects , Humans , Hypocalcemia/blood , Hypocalcemia/diagnosis , Hypocalcemia/epidemiology , Hypocalcemia/prevention & control , Imidazoles/adverse effects , Incidence , Retrospective Studies , Risk Assessment , Risk Factors , Severity of Illness Index , Time Factors , Treatment Outcome , Vitamin D Deficiency/complications , Vitamin D Deficiency/diagnosis , Zoledronic Acid
18.
Eur Urol ; 68(1): 42-50, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25449207

ABSTRACT

BACKGROUND: Previous studies have reported on prognostic factors for castration-resistant prostate cancer (CRPC); however, most of these studies were conducted before docetaxel chemotherapy was approved for CRPC. OBJECTIVE: To evaluate the prognostic value of multiple parameters in men with bone metastases due to CRPC using a contemporary dataset. DESIGN, SETTING, AND PARTICIPANTS: The analysis included 1901 patients with metastatic CRPC enrolled in an international, multicenter, randomized, double-blind phase 3 trial conducted between May 2006 and October 2009. OUTCOME MEASURES AND STATISTICAL ANALYSIS: We developed multivariate validated Cox proportional hazards models and nomograms to estimate 12-mo and 24-mo survival probabilities and median survival time. RESULTS AND LIMITATIONS: The median (95% confidence interval) overall survival was 20 (18, 21) mo. The final model included 12 of the 15 potential prognostic variables evaluated (concordance index 0.72). Seven bone-related variables were associated with longer survival in the final model: alkaline phosphatase ≤143 U/l (p<0.0001); bone-specific alkaline phosphatase (BSAP) <146 U/l (p<0.0001); corrected urinary N-telopeptide (uNTx) ≤50 nmol/mmol (p=0.0008); mild or no pain (Brief Pain Inventory-Short Form [BPI-SF] score ≤4) (p<0.0001); no previous skeletal-related event (SRE; p=0.0002); longer time from initial diagnosis to first bone metastasis (p<0.0001); and longer time from first bone metastasis to randomization (p<0.0001). Other significant predictors of improved survival included prostate-specific antigen (PSA) level <10 ng/ml (p<0.0001), hemoglobin >128g/l (p<0.0001), absence of visceral metastases (p<0.0001), Eastern Co-operative Oncology Group (ECOG) score ≤1 (p=0.017), and younger age (p=0.008). Nomograms were generated based on the parameters included in the final validated models (with/without uNTx and BSAP). One limitation was that lactate dehydrogenase (LDH) levels, a known prognostic factor, were not available in this study. CONCLUSIONS: Bone-related parameters are strong prognostic variables for overall survival in patients with bone metastases from CRPC. PATIENT SUMMARY: Survival time is variable in patients with bone metastases from prostate cancer. We found that factors related to bone help to predict how long a patient will live.


Subject(s)
Bone Neoplasms/secondary , Prostatic Neoplasms, Castration-Resistant/pathology , Adult , Age Factors , Aged , Aged, 80 and over , Alkaline Phosphatase/blood , Bone Density Conservation Agents/therapeutic use , Bone Neoplasms/drug therapy , Bone Neoplasms/metabolism , Collagen Type I/urine , Denosumab/therapeutic use , Diphosphonates/therapeutic use , Double-Blind Method , Hemoglobins/metabolism , Humans , Imidazoles/therapeutic use , Kallikreins/blood , Male , Middle Aged , Multivariate Analysis , Peptides/urine , Prognosis , Proportional Hazards Models , Prostate-Specific Antigen/blood , Prostatic Neoplasms, Castration-Resistant/metabolism , Prostatic Neoplasms, Castration-Resistant/mortality , Zoledronic Acid
19.
World J Urol ; 33(1): 131-5, 2015 Jan.
Article in English | MEDLINE | ID: mdl-24573904

ABSTRACT

PURPOSE: To investigate whether ultrasonographic bladder wall thickness (BWT) correlates with urodynamic parameters in patients with spinal cord injury (SCI). METHODS: Two hundred and seventy-two patients with SCI were enrolled in the study. All of the patients underwent bladder ultrasonography and urodynamic study. The anterior bladder wall was measured and compared to urodynamic data. RESULTS: The mean age of the patients was 37.4 years. The mean BWT was 3.9 mm. BWT was significantly higher in the patients with neurogenic detrusor overactivity associated with detrusor sphincter dyssynergia (NDO/DSD) compared to those without sphincter dyssynergia (4.2 vs. 3.6 mm, respectively, p < 0.001) and in those with compliance <20 ml/cm H2O. Nevertheless, ROC curve analysis [ROC = 0.624, 95 % CI (0.530, 0.718), p = 0.011] showed that no meaningful BWT measurement cutoff could be made to predict an elevated detrusor pressure in the storage phase. CONCLUSIONS: Increased BWT was present in patients with low bladder compliance and NDO/DSD. No BWT cutoff value to predict an elevated detrusor pressure was found. Therefore, the measurement of BWT has no clinical role in patients with SCI and cannot replace urodynamic evaluation.


Subject(s)
Spinal Cord Injuries/complications , Urinary Bladder, Neurogenic/diagnostic imaging , Urinary Bladder, Neurogenic/physiopathology , Urinary Bladder, Overactive/diagnostic imaging , Urinary Bladder, Overactive/physiopathology , Urodynamics/physiology , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Paraplegia/diagnostic imaging , Paraplegia/etiology , Paraplegia/physiopathology , Predictive Value of Tests , Quadriplegia/diagnostic imaging , Quadriplegia/etiology , Quadriplegia/physiopathology , ROC Curve , Spinal Cord Injuries/diagnostic imaging , Spinal Cord Injuries/physiopathology , Ultrasonography , Urinary Bladder, Neurogenic/etiology , Urinary Bladder, Overactive/etiology , Young Adult
20.
Int Braz J Urol ; 40(5): 596-604, 2014.
Article in English | MEDLINE | ID: mdl-25498270

ABSTRACT

INTRODUCTION: Urinary incontinence remains a major concern for patients undergoing radical prostatectomy. Its prevalence can reach 20% in the late postoperative period. MATERIALS AND METHODS: This clinical study investigated the differences of a dynamic evaluation of the urethra and pelvic floor contraction using perineal ultrasound in men without prostate surgery and in men submitted to radical prostatectomy with and without stress urinary incontinence. Ninety two male patients were included, which 70% of them underwent radical prostatectomy (RP) for more than one year. Thirty one men with clinically post prostatectomy incontinence were compared by two-dimensional (2D) perineal ultrasound to 34 patients without post prostatectomy incontinence and to 27 men without surgery in two centers in Brazil. RESULTS: Our results showed that the continent group presented the urethral angle at rest significantly lower than the prostate group (p = 0.0002). We also observed that the incontinent group showed the displacement of the anterior bladder neck during contraction significantly lower than the continent group (p = 0.008). CONCLUSIONS: We found that the continent group presented the urethral angle at rest significantly lower than the prostate group. The incontinent group also showed the anterior bladder neck displacement during contraction significantly lower than the continent group. It was more evident when the severe incontinent group and the continent group were compared.


Subject(s)
Prostatectomy/methods , Urinary Bladder/diagnostic imaging , Urinary Incontinence/diagnostic imaging , Aged , Analysis of Variance , Cross-Sectional Studies , Humans , Male , Middle Aged , Pelvic Floor/diagnostic imaging , Perineum/diagnostic imaging , Postoperative Period , Prostatectomy/adverse effects , Statistics, Nonparametric , Ultrasonography , Urinary Incontinence/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...